Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-05-22Clinical Trial Update: Chinese Liver Cancer Clinical Survey
Clinical trial update from Beijing Insight Science & Technology on a Chinese liver cancer study; the current status is UNKNOWN.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors
Clinical trial update detailing exhaustive genetic and immunological characterization of colorectal, kidney, and liver tumors.
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
This document provides an update on a clinical trial evaluating MRI/PET imaging to assess treatment response in patients with hepatocellular…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial comparing Apatinib plus Capecitabine versus Apatinib alone in patients with advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin, capecitabine, and cetuximab for advanced liver cancer (hepatocellular carcinoma) has completed. Result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma) [Phase 1]
A Phase 1, open-label, non-randomized multicenter dose-escalation study to assess safety and tolerability of OPB-111077 in subjects with adv…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)
Clinical trial NCT02093104 on liver embolization perfusion (TACE) has completed, in patients with unresectable hepatocellular carcinoma unde…
-
CLINICAL_TRIALS research · 2017-05-08Clinical Trial Update: Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma [NA]
This document provides an update on a clinical trial evaluating sorafenib as adjuvant therapy followed by radiofrequency ablation for recurr…
-
CLINICAL_TRIALS withdrawal · 2017-05-05Clinical Trial Update: Direct Peritoneal Resuscitation Plus Conventional Resuscitation [Phase 4]
The Phase 4 clinical trial NCT01882218 evaluating Direct Peritoneal Resuscitation plus Conventional Resuscitation for hepatocellular carcino…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC [Phase 2]
Phase 2 trial of RAD001 (everolimus) with transarterial chemoembolization for localized unresectable hepatocellular carcinoma has been termi…
-
CLINICAL_TRIALS research · 2017-05-03Clinical Trial Update: The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG [NA]
This clinical trial update explores the potential role of Gallium-68 PSMA PET imaging for staging, restaging, and monitoring response in hep…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1b/2 trial of oprozomib in combination with sorafenib for advanced hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis [Phase 2]
A Phase 2 trial evaluating palliative treatment for hepatocellular carcinoma in patients with Child-Pugh B cirrhosis has completed.
-
CLINICAL_TRIALS research · 2017-05-01Clinical Trial Update: Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
This completed clinical trial examined risk factors and molecular genomics in U.S. patients with chronic liver disease and hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: The Inflammatory Response to Stress and Angiogenesis in Liver Resection [NA]
This clinical trial update discusses a study evaluating the inflammatory response to stress and angiogenesis after liver resection in patien…
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma
A Phase III trial for post-operative HBV-related hepatocellular carcinoma was terminated; no efficacy results are reported in this update.
-
FDA label_change · 2017-04-27FDA Approved: STIVARGA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA page documents Bayer's supplemental application for Stivarga (regorafenib), indicating a label change is being sought.
-
CLINICAL_TRIALS research · 2017-04-27Clinical Trial Update: Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC [Phase 3]
This entry covers a Phase 3 clinical trial evaluating Cytokine-induced Killer (CIK) cells as therapy or adjuvant treatment for advanced hepa…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients
This clinical trial update summarizes biomarker analyses conducted in hepatocellular carcinoma patients treated with sorafenib.
-
CLINICAL_TRIALS research · 2017-04-26Clinical Trial Update: Quality of Life in Patients With Hepatocellular Carcinoma
Clinical trial update focusing on quality of life in patients with hepatocellular carcinoma, sponsored by Asan Medical Center. The current t…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) [Phase 1, Phase 2]
An update on a Phase 1/2 trial evaluating GPC3-targeted CAR-T cells delivered by intratumor injection for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial comparing sorafenib to 5-fluorouracil/mitomycin for metastatic hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy [Phase 2]
Phase 2 clinical trial investigating adoptive transfer of autologous natural killer (NK) cells to prevent recurrence of hepatocellular carci…
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) [Phase 1, Phase 2]
This trial update reports that the Tocilizumab study in patients with Hepatocellular Carcinoma undergoing transarterial chemoembolization ha…
-
CLINICAL_TRIALS research · 2017-04-21Clinical Trial Update: A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA [Phase 1, Phase 2]
This clinical trial updates a Phase 1/Phase 2 study evaluating autologous cytokine-induced killer (CIK) cell therapy in hepatocellular carci…